Prevalence &
Conditions
Interventions
Patients ages between 11-18 year old who received treatment at the Cardiac Unit, King Chulalongkorn Memorial Hospital and are currently prescribed spironolactone for more than 2 months ,Patients ages
Treatment,Treatment
Spironolactone group,Control group
Sponsors
Ratchadapiseksompotch Fund
Eligibility
Sex/Gender
All
Age
11 Years to 18 Years
Inclusion criteria
Inclusion criteria: 1. Patients ages between 11-18 years old who visit the cardiac outpatient or scheduled for hospital admission at the department of King Chulalongkorn Memorial Hospital 2. Currently prescribed spironolactone for a total duration of more than 3 months 3. Participants are currently not on any treatment for acne vulgaris 4. Participants give informed consent
Exclusion criteria
Exclusion criteria: 1.) Participants have underlying disease(s) (such as thyroid disorders) or are prescribed medications (such as steroids or anti-epileptic drugs) that are associated with risk of acne vulgaris or acneiform eruption
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prevalence of acne vulgaris Comprehensive Acne Severity Scale (CASS) | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects of spironolactone Questionnaire | — |
Countries
Thailand
Contacts
Public ContactNicharee Thamsirisup
Faculty of Medicine, Chulalongkorn University
Outcome results
None listed